[Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
Rinsho Ketsueki
; 47(7): 639-44, 2006 Jul.
Article
em Ja
| MEDLINE
| ID: mdl-16910574
ABSTRACT
We report the clinical courses of two cases with relapsed acute lymphoblastic leukemia (ALL) after allogeneic bone marrow transplantation (BMT). After reinduction chemotherapy, the patients received reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells harvested from their previous BMT donors. The conditioning regimen used consisted of fludarabine and melphalan. Graft-versus-host disease (GVHD) prophylaxis was performed with low dose cyclosporin A (CsA, 1 mg/kg/day d.i.v.) on its own. The regimen related toxicity was minimal, and stable engraftment was achieved. Since acute GVHD had not developed by day 30, CsA was stopped abruptly in both cases. After CsA withdrawal, acute GVHD developed, and subsequent chronic GVHD. One of two cases is alive without any relapse of the leukemia 40 months after the peripheral blood stem cell transplantation (PBSCT). In the other case, ALL relapsed 15 months after the PBSCT, however, complete remission was again induced concomitantly with reactivated GVHD. In both these cases, the results suggest that using PBSC as a stem cell source and abrupt cessation of GVHD prophylaxis provided a potent graft-versus-leukemia effect.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Doadores de Tecidos
/
Transplante de Medula Óssea
/
Condicionamento Pré-Transplante
/
Transplante de Células-Tronco de Sangue Periférico
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
Limite:
Child, preschool
/
Humans
/
Infant
/
Male
Idioma:
Ja
Ano de publicação:
2006
Tipo de documento:
Article